AI assistant
Sending…
DEXCOM INC — Director's Dealing 2010
Mar 16, 2010
30198_dirs_2010-03-16_33d6a91f-d521-452d-a204-72f16863d234.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-03-12
Reporting Person: YANG RICHARD (V.P., Strategic Affairs)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-12 | Incentive Stock Option (right to buy) | $9.8 | A | 6956 | Acquired | 2020-03-12 | Common Stock (6956) | Direct |
| 2010-03-12 | Non-Qualified Stock Option (right to buy) | $9.8 | A | 34044 | Acquired | 2020-03-12 | Common Stock (34044) | Direct |
Footnotes
F1: The option vests and becomes exercisable as to 1/36th each month beginning one month following the date of grant and becomes fully vested on the third anniversary of the date of grant.
F2: Not applicable
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17